Association between somatization subscale score and serotonin transporter availability in healthy volunteers—a single photon emission computed tomography study with [123I] ADAM

Rationale and objective Serotonin is one of the key neuromodulators involved in fundamental cerebral functions and behaviors. Previous study has demonstrated that somatization symptoms are probably associated with central serotonergic circuits, which are implicated in anxiety and nociception regulat...

Full description

Saved in:
Bibliographic Details
Published inPsychopharmacologia Vol. 219; no. 4; pp. 1011 - 1016
Main Authors Chou, Ming Hui, Chen, Kao Chin, Yeh, Tzung Lieh, Lee, I Hui, Yao, Wei Jen, Chen, Po See, Chang, Kang-Wei, Liao, Mei-Hsiu, Yang, Yen Kuang
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer-Verlag 01.02.2012
Springer
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Rationale and objective Serotonin is one of the key neuromodulators involved in fundamental cerebral functions and behaviors. Previous study has demonstrated that somatization symptoms are probably associated with central serotonergic circuits, which are implicated in anxiety and nociception regulation. This study aims to examine the correlation between somatization subscale score and serotonin transporter (SERT) availability in healthy volunteers. Methods Sixty-four healthy participants, 26 males and 38 females, were enrolled from the community and were administered the single somatization subscale of the Chinese symptom checklist 90 revised (SCL90-R). Single photon emission computed tomography with [ 123 I] 2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine was also performed to examine SERT availability. Results The somatization scores were negatively correlated with SERT availability (Spearman’s ρ  = −0.35, p  = 0.005), particularly in males (Spearman’s ρ  = −0.54, p  = 0.004). Conclusion This result reconfirmed the correlation between central serotonergic activity and the intensity of somatization symptoms, even in healthy participants. However, a gender difference exists in this correlation.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
content type line 23
ISSN:0033-3158
1432-2072
DOI:10.1007/s00213-011-2431-0